Integrative clinical and molecular analysis of advanced biliary tract cancers on immune checkpoint blockade reveals potential markers of response

BACKGROUND: While there have been encouraging preliminary clinical results for immune checkpoint inhibitors (ICIs) in BTCs, it remains a challenge to identify the subset of patients who may benefit. In this study, we evaluated the efficacy of ICI treatment in patients with advanced BTCs, and explore...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Jingjing, Wei, Qing, Wu, Xiaoying, Sima, Jun, Xu, Qi, Wu, Mengmeng, Wang, Fufeng, Mou, Haibo, Hu, Hanguang, Zhao, Jianguo, Li, Da, Hu, Jinlin, Zhang, Lingnan, Zhu, Xiu, Chen, Lei, Luo, Cong, Yan, Junrong, He, Jiachen, Ma, Yutong, Shao, Yang, Wu, Wei, Ying, Jieer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7423188/
https://www.ncbi.nlm.nih.gov/pubmed/32898339
http://dx.doi.org/10.1002/ctm2.118

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7423188/
https://www.ncbi.nlm.nih.gov/pubmed/32898339
http://dx.doi.org/10.1002/ctm2.118

Ejemplares similares